x min read

Best Stocks: FirstEnergy Corp. (NYSE:FE), Opexa Therapeutics, Inc. (NASDAQ:OPXA), Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Agree Realty Corp. (NYSE:ADC), NVE Corp. (NASDAQ:NVEC)

Best Stocks: FirstEnergy Corp. (NYSE:FE), Opexa Therapeutics, Inc. (NASDAQ:OPXA), Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Agree Realty Corp. (NYSE:ADC), NVE Corp. (NASDAQ:NVEC)
Written by
Charles Donlon
Published on
November 6, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

FirstEnergy Corp. (NYSE:FE) increased its profit during the latest quarter buoyed by boost in industrial energy use. The Akron-based company reported earnings of $333 million, or 79 cents a share, up from $218 million or 52 cents in the third quarter last year. Industrial sales increased by 3 percent, helping to balance a 6 percent decline in residential sales. Total revenue during the quarter dropped to nearly $3.9 billion from $4 billion. FirstEnergy owns the West Penn Power, Penelec, Met-Ed and Penn Power utilities in Western Pennsylvania, and is asking the state Public Utility Commission to approve a total $415 million rate increase, which would impact 2 million customers. Hearings in the case are scheduled throughout November. FirstEnergy Corp. (NYSE:FE) belongs to Utilities sector. Its net profit margin is 4.10% and weekly performance is 1.42%. On last trading day company shares ended up $37.10. FirstEnergy Corp. (NYSE:FE) distance from 50-day simple moving average (SMA50) is 6.82%. Opexa Therapeutics Inc. (NASDAQ:OPXA) a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis (MS) and neuromyelitis optica (NMO) today announced that the Company will report financial results for the three months ended September 30 2014 after the close of trading on Thursday November 6th. Opexa Therapeutics, Inc. (NASDAQ:OPXA) shares moved down -7.44% in last trading session and ended the day at $0.87. OPXA return on assets is -76.70%. Opexa Therapeutics, Inc. (NASDAQ:OPXA) quarterly performance is -38.73%. Threshold Pharmaceuticals Inc. (NASDAQ:THLD) reported ($0.15) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.12) by $0.03. The company had revenue of $3.70 million for the quarter, compared to the consensus estimate of $3.82 million. On 05 November, Threshold Pharmaceuticals Inc. (NASDAQ:THLD) shares moved down -4.93% and was closed at $2.70. THLD EPS growth in last 5 year was 24.30%. Threshold Pharmaceuticals Inc. (NASDAQ:THLD) year to date (YTD) performance is -42.18%. Agree Realty Corporation (NYSE:ADC) announced today that Daniel Lovitz will join the Company as Vice President of Acquisitions. Mr. Lovitz will work jointly with Geoff Linden, Vice President of Acquisitions, to continue expanding the Company's acquisition platform. In his new role, Mr. Lovitz will be primarily responsible for sourcing and underwriting retail net lease acquisitions in the southern half of the United States. Agree Realty Corp. (NYSE:ADC) ended the last trading day at $30.97. Company weekly volatility is calculated as 2.26% and price to cash ratio as 289.57. Agree Realty Corp. (NYSE:ADC) showed a weekly performance of 5.38%. NVE Corp (NASDAQ:NVEC) released its earnings data on Wednesday. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.05. The company had revenue of $8.27 million for the quarter, compared to the consensus estimate of $8.10 million. During the same quarter in the previous year, the company posted $0.66 earnings per share. NVE Corp. (NASDAQ:NVEC) shares advanced 1.07% in last trading session and ended the day at $75.22. NVEC Gross Margin is 79.50% and its return on assets is 12.30%. NVE Corp. (NASDAQ:NVEC) quarterly performance is 11.12%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.